TrialBlood2016

A first-in-human phase 1 study of ACE910, a novel factor VIII-mimetic bispecific antibody, in healthy subjects.

Naoki Uchida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.